Analyze Diet
Veterinary research2004; 35(4); 411-423; doi: 10.1051/vetres:2004023

Current perspectives on control of equine influenza.

Abstract: Influenza A viruses of the H3N8 subtype are a major cause of respiratory disease in horses. Subclinical infection with virus shedding can occur in vaccinated horses, particularly where there is a mismatch between the vaccine strains and the virus strains circulating in the field. Such infections contribute to the spread of the disease. Rapid diagnostic techniques are available for detection of virus antigen and can be used as an aid in control programmes. Improvements have been made to methods of standardising inactivated virus vaccines, and a direct relationship between vaccine potency measured by single radial diffusion and vaccine-induced antibody measured by single radial haemolysis has been demonstrated. Improved adjuvants and antigenic presentation systems extend the duration of immunity induced by inactivated virus vaccines, but high levels of antibody are required for protection against field infection. In addition to circulating antibody, infection with influenza virus stimulates mucosal and cellular immunity; unlike immunity to inactivated virus vaccines, infection-induced immunity is not dependent on the presence of circulating antibody to HA. Live attenuated or vectored equine influenza vaccines, which may better mimic the immunity generated by influenza infection than inactivated virus vaccines, are now available. Mathematical modelling based upon experimental and field data has been applied to examine issues relating to vaccine efficacy at the population level. A vaccine strain selection system has been implemented and a more global approach to the surveillance of equine influenza is being developed.
Publication Date: 2004-07-09 PubMed ID: 15236674DOI: 10.1051/vetres:2004023Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper discusses the control of equine influenza (horse flu) caused by certain variations of the Influenza A virus. Notably highlighting that in spite being vaccinated, horses can still carry the virus and spread the disease under certain circumstances. Developments in vaccination, diagnostic techniques, and global surveillance of the disease are also touched on in this research article.

Disease Control Strategies

  • In the fight against equine influenza, the paper reveals that subclinical infections can still happen even in vaccinated horses, particularly if there’s a discrepancy between the strains in the vaccine and those in the field. In such cases, afflicted horses may still shed the virus, inadvertently promoting its spread.
  • To counteract this, rapid diagnostic techniques, capable of detecting influenza virus antigens, have been established to aid control schemes. This helps to swiftly identify and isolate carriers, thereby mitigating the spread of infection.

Vaccine Standardization and Efficacy

  • The research talks about advancements in the standardization of inactivated virus vaccines. A correlation has been found between vaccine effectiveness, represented by single radial diffusion (a technique to measure varyuing concentrations of antigen in the vaccine) and the vaccine-triggered antibody response, shown by single radial haemolysis (a technique for measuring the antibody in serum).
  • Besides these, the paper states that augmented adjuvants (substances which improve the body’s immune response to a vaccine) and antigen presentation systems aid in prolonging the immunity duration provided by inactivated virus vaccines.
  • However, it’s important to note that a high level of antibodies is crucial in safeguarding against a field infection.

Live Attenuated Vaccines and Immunity

  • This research paper also throws light on more contemporary types of vaccines available now, namely live attenuated or vectored equine influenza vaccines. These vaccines are believed to better simulate the immunity generated by an actual influenza infection, as opposed to inactivated virus vaccines.
  • This paper also points out that in addition to circulating antibodies, an influenza virus infection can stimulate mucosal and cellular immunities. Unlike inactivated virus vaccines’ immunity, the immunity induced via infection doesn’t depend on the presence of “circulating antibody to HA” or the Hemagglutinin antigen on the influenza virus.

Mathematical Models and Global Surveillance

  • An interesting aspect discussed by the authors is the application of mathematical modelling, based on experimental and field data, to study issues related to vaccine efficacy at a community level.
  • Further, a worldwide surveillance system is being developed to monitor equine influenza and a vaccine strain selection process has been implemented to improve the effectiveness of the vaccines.

Cite This Article

APA
Daly JM, Newton JR, Mumford JA. (2004). Current perspectives on control of equine influenza. Vet Res, 35(4), 411-423. https://doi.org/10.1051/vetres:2004023

Publication

ISSN: 0928-4249
NlmUniqueID: 9309551
Country: England
Language: English
Volume: 35
Issue: 4
Pages: 411-423

Researcher Affiliations

Daly, Janet M
  • Centre for Preventive Medicine, Animal Health Trust, Lanwades Park, Kentford, Newmarket, Suffolk, CB8 7UU, United Kingdom. janet.daly@aht.org.uk
Newton, J Richard
    Mumford, Jennifer A

      MeSH Terms

      • Animals
      • Horse Diseases / epidemiology
      • Horse Diseases / prevention & control
      • Horse Diseases / virology
      • Horses
      • Influenza A virus / pathogenicity
      • Influenza Vaccines
      • Orthomyxoviridae Infections / prevention & control
      • Orthomyxoviridae Infections / veterinary
      • Orthomyxoviridae Infections / virology
      • Vaccination / veterinary

      Citations

      This article has been cited 9 times.
      1. El-Hage C, Hartley C, Savage C, Watson J, Gilkerson J, Paillot R. Assessment of Humoral and Long-Term Cell-Mediated Immune Responses to Recombinant Canarypox-Vectored Equine Influenza Virus Vaccination in Horses Using Conventional and Accelerated Regimens Respectively. Vaccines (Basel) 2022 May 26;10(6).
        doi: 10.3390/vaccines10060855pubmed: 35746463google scholar: lookup
      2. Oladunni FS, Oseni SO, Martinez-Sobrido L, Chambers TM. Equine Influenza Virus and Vaccines. Viruses 2021 Aug 20;13(8).
        doi: 10.3390/v13081657pubmed: 34452521google scholar: lookup
      3. Pavulraj S, Bergmann T, Trombetta CM, Marchi S, Montomoli E, Alami SSE, Ragni-Alunni R, Osterrieder N, Azab W. Immunogenicity of Calvenza-03 EIV/EHV(®) Vaccine in Horses: Comparative In Vivo Study. Vaccines (Basel) 2021 Feb 17;9(2).
        doi: 10.3390/vaccines9020166pubmed: 33671378google scholar: lookup
      4. Singh RK, Dhama K, Karthik K, Khandia R, Munjal A, Khurana SK, Chakraborty S, Malik YS, Virmani N, Singh R, Tripathi BN, Munir M, van der Kolk JH. A Comprehensive Review on Equine Influenza Virus: Etiology, Epidemiology, Pathobiology, Advances in Developing Diagnostics, Vaccines, and Control Strategies. Front Microbiol 2018;9:1941.
        doi: 10.3389/fmicb.2018.01941pubmed: 30237788google scholar: lookup
      5. Paillot R. A Systematic Review of Recent Advances in Equine Influenza Vaccination. Vaccines (Basel) 2014 Nov 14;2(4):797-831.
        doi: 10.3390/vaccines2040797pubmed: 26344892google scholar: lookup
      6. Boukharta M, Zakham F, Touil N, Elharrak M, Ennaji MM. Cleavage site and Ectodomain of HA2 sub-unit sequence of three equine influenza virus isolated in Morocco. BMC Res Notes 2014 Jul 12;7:448.
        doi: 10.1186/1756-0500-7-448pubmed: 25016480google scholar: lookup
      7. Ault A, Zajac AM, Kong WP, Gorres JP, Royals M, Wei CJ, Bao S, Yang ZY, Reedy SE, Sturgill TL, Page AE, Donofrio-Newman J, Adams AA, Balasuriya UB, Horohov DW, Chambers TM, Nabel GJ, Rao SS. Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies. Vaccine 2012 Jun 6;30(26):3965-74.
        doi: 10.1016/j.vaccine.2012.03.026pubmed: 22449425google scholar: lookup
      8. Bountouri M, Fragkiadaki E, Ntafis V, Kanellos T, Xylouri E. Phylogenetic and molecular characterization of equine H3N8 influenza viruses from Greece (2003 and 2007): evidence for reassortment between evolutionary lineages. Virol J 2011 Jul 14;8:350.
        doi: 10.1186/1743-422X-8-350pubmed: 21756308google scholar: lookup
      9. Weidinger AK, Bergmann M, König M, Zablotski Y, Hartmann K. Anti-rabies humoral immune response in cats after concurrent vs separate vaccination against rabies and feline leukaemia virus using canarypox-vectored vaccines. J Feline Med Surg 2024 Feb;26(2):1098612X231218643.
        doi: 10.1177/1098612X231218643pubmed: 38358295google scholar: lookup